| pubmed-article:9150811 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9150811 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9150811 | lifeskim:mentions | umls-concept:C0013072 | lld:lifeskim |
| pubmed-article:9150811 | lifeskim:mentions | umls-concept:C0036579 | lld:lifeskim |
| pubmed-article:9150811 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:9150811 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:9150811 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9150811 | pubmed:dateCreated | 1997-7-7 | lld:pubmed |
| pubmed-article:9150811 | pubmed:abstractText | To assess the therapeutic efficacy of selegiline combined with levodopa in the long-term treatment of Parkinson's disease (PD). | lld:pubmed |
| pubmed-article:9150811 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9150811 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9150811 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9150811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9150811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9150811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9150811 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9150811 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9150811 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:9150811 | pubmed:issn | 0001-6314 | lld:pubmed |
| pubmed-article:9150811 | pubmed:author | pubmed-author:MyllyläV VVV | lld:pubmed |
| pubmed-article:9150811 | pubmed:author | pubmed-author:SotaniemiK... | lld:pubmed |
| pubmed-article:9150811 | pubmed:author | pubmed-author:Mäki-IkolaOO | lld:pubmed |
| pubmed-article:9150811 | pubmed:author | pubmed-author:HeinonenE HEH | lld:pubmed |
| pubmed-article:9150811 | pubmed:author | pubmed-author:HakulinenPP | lld:pubmed |
| pubmed-article:9150811 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9150811 | pubmed:volume | 95 | lld:pubmed |
| pubmed-article:9150811 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9150811 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9150811 | pubmed:pagination | 211-8 | lld:pubmed |
| pubmed-article:9150811 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:meshHeading | pubmed-meshheading:9150811-... | lld:pubmed |
| pubmed-article:9150811 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9150811 | pubmed:articleTitle | Selegiline as the primary treatment of Parkinson's disease--a long-term double-blind study. | lld:pubmed |
| pubmed-article:9150811 | pubmed:affiliation | Department of Neurology, Oulu University Hospital, Finland. | lld:pubmed |
| pubmed-article:9150811 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9150811 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9150811 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9150811 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9150811 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9150811 | lld:pubmed |
